OCF Can Repress Tumor Metastasis by Inhibiting Epithelial–mesenchymal Transition Involved in PTEN/PI3K/AKT Pathway in Lung Cancer Cells

PLoS ONE - United States
doi 10.1371/journal.pone.0174021
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

DCLK1 Promotes Epithelial-Mesenchymal Transition via the PI3K/Akt/NF-κB Pathway in Colorectal Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

STYK1 Promotes Epithelial-Mesenchymal Transition and Tumor Metastasis in Human Hepatocellular Carcinoma Through MEK/ERK and PI3K/AKT Signaling

Scientific Reports
Multidisciplinary
2016English

Blocking PI3K/Akt Signaling Attenuates Metastasis of Nasopharyngeal Carcinoma Cells Through Induction of Mesenchymal-Epithelial Reverting Transition

Oncology Reports
MedicineCancer ResearchOncology
2014English

JARID2 Promotes Invasion and Metastasis of Hepatocellular Carcinoma by Facilitating Epithelial-Mesenchymal Transition Through PTEN/AKT Signaling

Oncotarget
Oncology
2016English

MiR-206 Inhibits HGF-induced Epithelial-Mesenchymal Transition and Angiogenesis in Non-Small Cell Lung Cancer via C-Met /PI3k/ Akt/mTOR Pathway

Oncotarget
Oncology
2016English

Buyang Huanwu Tang Inhibits Cellular Epithelial-To-Mesenchymal Transition by Inhibiting TGF-β1 Activation of PI3K/Akt Signaling Pathway in Pulmonary Fibrosis Model in Vitro

BMC Complementary Medicine and Therapies
2020English

MicroRNAs and the PTEN/PI3K/Akt Pathway in Gastric Cancer (Review)

Oncology Reports
MedicineCancer ResearchOncology
2019English

The Role of the PTEN/PI3K/Akt Pathway on Prognosis in Epithelial Ovarian Cancer: A Meta-Analysis

Oncologist
Cancer ResearchMedicineOncology
2014English

Mn12Ac Inhibits the Migration, Invasion and Epithelial‑mesenchymal Transition of Lung Cancer Cells by Downregulating the WNT/Β‑catenin and PI3K/AKT Signaling Pathways

Oncology Letters
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy